TRANSCEPT PHARMACEUTICALS
Transcept Pharmaceuticals, Inc. uses its proprietary delivery system to enhance the penetration of drugs, significantly speeding their onset of action. Transcept is developing rapid-acting versions of several major market pharmaceuticals. Hamilton co-invested in the company's first institutional round of funding alongside Montreaux Equity Partners, Peninsula Equity Partners and Vivo Ventures. Investors in subsequent financing rounds include these firms, and New Leaf Venture Partners, Interwest Partners and New Enterprise Associates.
TRANSCEPT PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Neuroscience Pharmaceutical Therapeutics
Founded:
2001-01-01
Address:
Richmond, California, United States
Country:
United States
Website Url:
http://www.transoral.com
Total Employee:
11+
Status:
Closed
Contact:
(510) 215-3500
Email Addresses:
[email protected]
Total Funding:
40 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Amazon Organization Schema
Current Advisors List
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2009-02-02 | Novacea | Novacea acquired by Transcept Pharmaceuticals | N/A |
Investors List
Hercules Capital
Hercules Capital investment in Series D - Transcept Pharmaceuticals
Peninsula Ventures
Peninsula Ventures investment in Series D - Transcept Pharmaceuticals
InterWest Partners
InterWest Partners investment in Series D - Transcept Pharmaceuticals
Vivo Capital
Vivo Capital investment in Series D - Transcept Pharmaceuticals
Hamilton BioVentures
Hamilton BioVentures investment in Series D - Transcept Pharmaceuticals
Montreux Equity Partners
Montreux Equity Partners investment in Series D - Transcept Pharmaceuticals
New Leaf Venture Partners
New Leaf Venture Partners investment in Series D - Transcept Pharmaceuticals
New Enterprise Associates
New Enterprise Associates investment in Series D - Transcept Pharmaceuticals
Sofinnova Investments
Sofinnova Investments investment in Series A - Transcept Pharmaceuticals
Official Site Inspections
http://www.transoral.com
- Host name: a904c694c05102f30.awsglobalaccelerator.com
- IP address: 76.223.54.146
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108